Rochester, NY 7/14/2009 7:42:14 AM
After Market Report - CTIC - Cell Therapeutics Submits New Drug Application to FDA - Sourced WhisperFromWallStreet.com
Cell Therapeutics, Inc.
After Market Report - CTIC - Cell Therapeutics Submits New Drug Application to FDA - Sourced WhisperFromWallStreet.com
Cell Therapeutics, Inc., CTIC
Cell Therapeutics, Inc. (CTI) announced that it has completed the submission of the New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for pixantrone to treat relapsed or refractory, aggressive non-Hodgkin's lymphoma (NHL). Cell Therapeutics, Inc. (CTI) requested priority review, which if granted could lead to an approval decision from the FDA in the fourth quarter of 2009. Pixantrone is currently available in Europe on a named-patient basis.
ABOUT
Cell Therapeutics, Inc., a biopharmaceutical company, develops, acquires, and commercializes oncology products for cancer treatment. Its development portfolio includes Pixantrone, a phase III trial product, for non-Hodgkin?s lymphoma; Brostallicin, which is in first-line Phase II study for the treatment of sarcoma; and OPAXIO, a chemotherapeutic agent for the potential treatment of non-small cell lung, ovarian, and other cancers. It has collaboration and licensing arrangements with Novartis International Pharmaceutical, Ltd.; and PG-TXL Company, L.P. The company was founded in 1991 and is headquartered in Seattle, Washington.
Last Trade: 1.38
Day's Range: 1.35 - 1.41
52wk Range: 0.05 - 4.50
Volume: 8,998,993
WhisperfromWallStreet.com has a proven track record in picking winning stocks. While neither we nor anyone can offer a guarantee, we scan countless stocks on a daily basis to seek out those that have the greatest opportunity for gain. When we find these stocks, we immediately send an alert to our membership. Please feel free to track our results by joining our newsletter free. So far in 2009 we have sent over 40 alerts to our members with an average gain of over 80%.
Join our stock alert service free.
If you're an investor and interested in knowing which penny stocks are getting ready to run, sign up for our penny alerts at http://whisperfromwallstreet.com/
During 2009 we have sent out over 40 stock alerts resulting in an over 80% price gain. Sign up now FREE to track our results.
---
Disclaimer: Full disclaimer at http://whisperfromwallstreet.com/disclaimer.php
IMPORTANT NOTE: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. This press release should not be construed as a solicitation to buy or sell any particular stock or security. Neither WhisperfromWallstreet, nor any of its affiliates are registered investment advisors or broker dealers.
